ImpediMed Ltd - Company Profile
Powered by 
All the sales intelligence you need on ImpediMed Ltd in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how ImpediMed Ltd fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with ImpediMed Ltd.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
The following section provides information on ImpediMed Ltd’s senior management, executives, CEO and key decision makers and their roles in the organization. For more insight into ImpediMed Ltd's management and employees, unlock the full data with our company analytics monitoring tool.
Executives
Erik Anderson
Managing Director; Director; Chief Executive Officer Executive BoardMr. Erik Anderson has been the Chief Executive Officer, Managing Director and Director of the company since 2026. Prior to this, he served as President of the Breast and Skeletal Health Division at Hologic, Inc.
McGregor Grant
Director; Chief Financial Officer Executive BoardMr. McGregor Grant has been the Chief Financial Officer and Director of the company since 2023. Prior to this, he was the Chief Financial Officer and Company Secretary of Nanosonics Limited. Mr. Grant has extensive international experience gained with Invacare as its Asia Pacific Finance Director and Abbott Laboratories in several senior finance roles located in Australia and the United States. Previously, he worked for Coopers & Lybrand (now PwC) in Australia and Europe.
Steven Chen
Chief Medical Officer Senior ManagementDr. Steven Chen is the Chief Medical Officer of the company. Prior to this, he served as the Chief Medical Officer for Avelas Biosciences. Previously, Dr. Chen served as the Chief of Breast Surgery at UC Davis Medical Center and as the President of the American Society of Breast Surgeons.
Christine Emmanuel-Donnelly
Chairperson Non Executive BoardMs. Christine Emmanuel-Donnelly has been the Chairperson of the company since 2023. Prior to this, she served in commercialization and intellectual property roles at CSIRO and RMIT. Currently, Ms. Emmanuel-Donnelly serves as a Non-Executive Director for PolyNovo and Medical Developments International and Pikcha Holdings Pty Ltd (trading as Seminal).
Dennis Schlaht
Senior Vice President - R&D and Technology Senior ManagementStill looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer